Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Patients play an active role in their treatment

Rheumatoid Arthritis Patient-Reported Survey Data | 2020

August 27, 2020

Only 16% of people living with rheumatoid arthritis feel controlled on their current treatment plan, according to new Health Union survey data.

Two phones are connected with a wire in the shape of a heart

Social Media Communities in Times of Physical Distance

August 20, 2020

While COVID-19 has resulted in a need to physically isolate, experts are concerned that the associated social isolation will have negative consequences.

Lung Cancer Patient-Reported Survey Data | 2020

August 13, 2020

Many people living with lung cancer report feeling a stigma associated with their condition, according to new Health Union survey data.

Playing an Active Role in Treatment Yields More Confidence in Patients

August 4, 2020

Whether a person plays an active role in treatment or not, the majority of patients surveyed do not feel controlled on their current treatment plan.

How to Provide Value that Benefits Patients (and Your Brand)

April 8, 2022

While there are commonalities across the board, the top three resources that provide value for patients vary by therapeutic area and specific condition.

3 Reasons for Pharma Marketers to Leverage Social Health

April 5, 2022

Health Union’s published analysis in the Journal of Medical Internet Research and a recent survey of 2,371 patients demonstrate the value of social health.

Patient Impact Drives Shift in Engagement at Reuters Pharma USA

March 30, 2022

Pharma USA 2022 played an integral role in recognizing the need for the industry to shift priorities towards community-first patient engagement strategies.

Nutrition, Social Health & Chronic Conditions: Why It Matters to Pharma

March 23, 2022

Understanding the nuances and complexities of nutrition-related social health conversations can help pharma best meet the needs of patients.

Healthcare Industry Thought Leadership

Contact